##plugins.themes.academic_pro.article.main##
Abstract
Assessment of patient management tactics and the effectiveness of polycystic ovary syndrome (PCOS) therapy, taking into account modern international recommendations. Inadequate assessment of the menstrual cycle without taking into account modern characteristics of the normal menstrual cycle leads to overdiagnosis and, as a result, the appointment of unnecessary therapy. The incidence of PCOS among women of young fertile age with menstrual disorders was 49.5%. Clinical hyperandrogenism of varying severity was detected in all patients with PCOS. The use of microdosed COCs containing drospirenone in the treatment of PCOS in 93% of cases reduces the severity of clinical hyperandrogenism, normalizes the menstrual cycle and improves anxiety indicators by 16.5%
Keywords
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
- Adamyan L.V., Andreeva E.N., Gasparyan S.A. and others. Polycystic ovary syndrome in reproductive age (modern approaches to diagnosis and treatment). Clinical recommendations (treatment protocol). M.; 2015.
- Panarina O.V., Rashidova M.A., Belenkaya L.V. and others. Modern ideas about the pathogenesis of polycystic ovary syndrome (literature review). The scientific act of biomedicine. 2017;2(4):9-14.
- Tiede H., Misso M., Costello M., et al. International evidence-based guidelines for the Assessment and Management of Polycystic Ovary Syndrome 2018. Monash University: Melbourne, Australia; 2018.
- Beglova A.Yu., Elgina S.I. Phenotypic features of the level of anti-muller hormone and ultrasound parameters of the ovaries in women of reproductive age with polycystic ovary syndrome. Mother and child in Kuzbass. 2019;1(76):10-14.
- Bulavenko O.V. Antimuller hormone as a marker of a woman's reproductive system. Reproductive endocrinology. 2011;1:27-29. DO IT: 10.18370/2309-4117.2011.1.27-29.
- GRLS. Instructions for the use of the drug for medical use of Dimia. (Electronic resource). URL: https:// grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=5921317a-35ac-4ff5-9067-cb8e97fb3b9eandt =. Date of application: 06.12.2019.
- Medical criteria for the acceptability of the use of contraceptive methods. WHO 2012, 4th ed. M.; 2012.
- Medical criteria for the acceptability of the use of contraceptive methods. WHO 2015, 5th ed. Geneva; 2015.
- Muek A.O., Seeger H., Rabe T. Hormonal contraception and the risk of endometrial cancer: a systematic review. Endocrine cancer. 2010;17: R263–R271. DOI: 10.1677/ERC-10-0076.